# Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation

> **NCT02313792** · PHASE3 · UNKNOWN · sponsor: **The Catholic University of Korea** · enrollment: 88 (estimated)

## Conditions studied

- Mucositis

## Interventions

- **DRUG:** Palifermin

## Key facts

- **NCT ID:** NCT02313792
- **Lead sponsor:** The Catholic University of Korea
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2015-03
- **Final completion:** 2015-06
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2014-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02313792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02313792, "Palifermin for Patients Receiving Hematopoietic Stem Cell Transplantation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02313792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*